• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Strategy for Assessment of the Colloidal and Biological Stability of H1N1 Influenza A Viruses

tetano

Editor, Senior Moderator
Int J Pharm. 2016 Nov 29. pii: S0378-5173(16)31121-8. doi: 10.1016/j.ijpharm.2016.11.058. [Epub ahead of print]
[h=1]Strategy for Assessment of the Colloidal and Biological Stability of H1N1 Influenza A Viruses.[/h] H?mmerling F[SUP]1[/SUP], Lorenz-Cristea O[SUP]2[/SUP], Baumann P[SUP]3[/SUP], Hubbuch J[SUP]4[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Current influenza vaccines are mostly formulated as liquids which requires a continuous cold chain to maintain the stability of the antigen. For development of vaccines with an increased stability at ambient temperatures, manifold parameters and their influences on the colloidal stability and activity of the antigen have to be understood. This work presents a strategy to examine both, the colloidal stability and the remaining biological activity of H1N1 influenza viruses under various conditions after an incubation of 40 days. H1N1 phase diagrams were generated for several pH values and different initial H1N1 and NaCl concentrations. It was shown that the highest H1N1 recoveries were obtained for pH 6 and that moderate amounts of NaCl are favorable for increased recoveries. In contrast to colloidal stability, the highest remaining HA activity was observed at pH 9. The electrostatic and hydrophobic surface properties of H1N1 were investigated to reveal the mechanisms accounting for the decrease in stability. Secondly, the capability of virus precipitation by polyethylene glycol in combination with determination of surface hydrophobicity was proven to be useful as a predictive tool to rank stability under different conditions. This methodology enables the rapid assessment of aggregation propensity of H1N1 formulations and the influence on the activity of the virus particles and might become a standard tool during the development of vaccine formulations.
Copyright © 2016 Elsevier B.V. All rights reserved.


[h=4]KEYWORDS:[/h] Formulation; Pandemic influenza virus; Stability; Surface properties; Virus phase diagram

PMID: 27913239 DOI: 10.1016/j.ijpharm.2016.11.058
[PubMed - as supplied by publisher]
 
Back
Top Bottom